Universal face masking reduces endophthalmitis incidence during anti-VEGF injections

Dr Sunir J. Garg speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.

Ophthalmology Times Europe's Sheryl Stevenson speaks with Dr Sunir J. Garg, co-director of retina research at the Wills Eye Hospital in Baltimore, Maryland, United States, on the highlights of his presentation at the 2021 annual American Academy of Ophthalmology (AAO) meeting regarding the impact of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injections.

The American Academy of Ophthalmology (AAO) annual meeting was held November 12 to 15 at the Ernest N. Morial Convention Centre in New Orleans, Louisiana, United States. The event included Subspecialty Days and a virtual component for remote participation.

Related Content: Additional AAO content | Retina | Inflammation & Infection

Related Videos
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
Trukera Medical rebranding ushers in new era of expansion into cornea market
2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent
Younger patients often require repeat corneal crosslinking, study finds
Investigators report positive visual outcomes one year after monocular implantation of small aperture IOL
Fluid dynamics in wet macular degeneration: How fluid type affects visual acuity
Related Content
© 2023 MJH Life Sciences

All rights reserved.